Sackler family extraction from Purdue Pharma (2008-2017)

Documented totalUSD $10.70B

As of2019-09-15

Confidence[SECONDARY]

Source

Distributions from Purdue Pharma to Sackler-family trusts and entities during the period of escalating OxyContin litigation. Established by court-appointed monitor's report in In re Purdue Pharma L.P. (Bankr. S.D.N.Y. Case No. 19-23649) and corroborated by subsequent NY AG and MA AG investigations.

Flow Diagram

Hops

Dividend · secondary · 2017-12-31

Purdue Pharma L.P. (OxyContin sales revenue) → Sackler-family controlled trusts and entities (aggregate)

USD $10.70B (Aggregate distributions 2008-2017 per court-appointed monitor findings. The flow is the structured pattern, not a single transfer; the figure is the cumulative monitor-established sum.)

⛔ Vanish point — Trust with unnamed beneficiary

Trust structures shield individual Sackler-family-member beneficial ownership. The 2019 Chapter 11 plan attempted to channel further claims into a settlement trust with broad non-debtor releases; SCOTUS struck the release mechanism in Harrington v. Purdue Pharma, 603 U.S. ___ (2024). State fraudulent-transfer litigation remains active in multiple jurisdictions.

Harrington v. Purdue Pharma L.P., 603 U.S. ___ (2024) ↗

Cited by Shadow Ledger dossiers

Sackler family wealth extraction via Purdue dividends + bankruptcy shield (profit_mechanism)

Methodology

How amounts are sourced. Dollar figures are drawn from public disclosure filings: USASpending.gov for federal contracts, FEC filings for political contributions, SEC EDGAR for corporate disclosures, LD-2 lobbying registrations for lobbying expenditures, and Congressional records for appropriations. Each hop carries its own citations linking to the primary filing. Where an amount is unavailable (classified contracts, private transactions), the hop is marked "undisclosed" rather than estimated.

About vanish points. A vanish point marks the node at which the money trail goes dark. Each marker carries a typed reason from a fixed taxonomy (shell company, offshore jurisdiction, undisclosed beneficial owner, etc) and a curator note describing what is and isn't known. Vanish points are highlighted in red in the flow diagram above. They are evidence of opacity, not endpoints — every reason is a documented systemic feature of the disclosure regime that prevents further tracing.

Confidence tiers. Each hop and chain carries a confidence rating: primary (sourced directly from official filings), secondary (sourced from reporting or derived records), or inferential (existence is established but details are reconstructed from indirect evidence).

PROVE IT How verification works →